Furthermore, patients with gastric cancer featuring low VPS9D1-AS1 expression are expected to show shorter overall survival and shorter disease-free survival than patients with high VPS9D1-AS1 expression [23]. This evidence concerns the gene VPS9D1 and gastric cancer.